Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 2, 1997, Pages 145-152

  Simpson, B Joyce ^a   Shapiro, Eugene D ^b   Andiman, Warren A ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4+ T lymphocytes; Human immunodeficiency virus; Pregnancy; Vertical transmission; Zidovudine

Indexed keywords

ZIDOVUDINE;

ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031055575     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199702010-00007     Document Type: Article

References (27)

1. Andiman WA, Simpson BJ, Olson B, Dember L, Silva TJ, Miller G. Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Am J Dis Child 1990; 144:758-66.
2. European Collaborative Study. Mother-to-child transmission of HIV infection. Lancet 1988;2:1039-42.
3. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet 1988; 2:1043-5.
4. Hutto C, Parks WP, Lai S. A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr 1991;118:347-53.
5. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991;337:253-60.
6. Centers for Disease Control. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987;36:225-30,235.
7. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, Vol. 43/No. RR-12.
8. Simpson BJ, Andiman WA. Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics 1994;93:840-2.
9. Ikeda M, Andiman WA, Mezger J, Shapiro ED, Miller G. Quantitative leukoviremia and immune complex-dissociated antigenemia as predictors of infection status in children born to HIV-1 seropositive mothers. J Pediatr 1993;122:524-31.
10. Andiman WA, Silva TJ, Shapiro ED, O'Connor T, Olson B. Predictive value of the human immunodeficiency virus 1 antigen test in children born to infected mothers. Pediatr Infect Dis J 1992;11:436-40.
11. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic immunodeficiency virus infection. N Engl J Med 1990;332:941-9.
12. Mehta C, Patel N. StatXact. Cambridge, Massachusetts: Cytel Software, 1991.
13. Gustafson TL. True epistat, 5th ed. Richardson, Texas: Epistat Services, 1994.
14. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992. Vol. 41/No. RR-17.
15. Matheson PB, Abrams EJ, Thomas PA, et al. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 1995; 117:353-8.
16. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
17. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996;275:1483-8.
18. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-42.
19. + lymphocytes, and placental inflammation. JAMA 1993;269:2853-9.
20. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343: 1464-7.
21. Kind C, Brandle B, Wyler C-A, et al. Epidemiology of vertical transmission in Switzerland: results of a nationwide prospective study. Eur J Pediatr 1992;151:442-8.
22. Gabiano C, Tovo P, deMartino M, et al. Mother to child transmission of HIV 1: risk of infection and correlates of transmission. Pediatrics 1992;90:362-74.
23. Tovo P, deMartino M, Gabiano C, et al. Mode of delivery and gestational age influence perinatal transmission. J Acquir Immun Defic Syndr Hum Retrovirol 1996;11:88-94.
24. Dunn DT, Newell ML, Mayaux MJ, et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immun Defic Syndr 1994;7:1064-6.
25. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996;334: 1617-23.
26. Dugliege A-M, Amos CI, Felton S, et al. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J Pediatr 1995;126:625-32.
27. Nesheim S, Shaffer N, Vink P, et al. Lack of increased risk for perinatal human immunodeficiency virus transmission to subsequent children born to infected women. Pediatr Infect Dis J 1996;15:586-90.